Parkinson disease trials in Croatia

1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

  Where

  Grad Zagreb, Rijeka

  Age

  18 years to 69 years

  People

  100 worldwide

  Run by

  AbbVie

  See details and how to joinNCT07227896